Neuroimaging in Addiction
Herausgeber: Adinoff, Bryon; Stein, Elliot A
Neuroimaging in Addiction
Herausgeber: Adinoff, Bryon; Stein, Elliot A
- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Neuroimaging in Addiction presents an up-to-date, comprehensive review of the functional and structural imaging human studies that have greatly advanced our understanding of this complex disorder. Approaching addiction from a conceptual rather than a substance-specific perspective, this book integrates broad neuropsychological constructs that consider addiction as a neuroplastic process with genetic, developmental, and substance-induced contributions. The internationally recognized contributors to this volume are leaders in clinical imaging with expertise that spans the addiction spectrum.…mehr
Andere Kunden interessierten sich auch für
- Jaak Panksepp (Hrsg.)Textbook of Biological Psychiatry239,99 €
- Novartis FoundationUnderstanding Nicotine and Tobacco Addiction257,99 €
- Michael R. TrimbleBiological Psychiatry119,99 €
- Bryan LaskEating Disorders and the Brain113,99 €
- Andrew E. BudsonThe Handbook of Alzheimer's Disease and Other Dementias259,99 €
- Malcolm MacleodNeurology43,99 €
- Teofilo L. Lee-Chiong (Hrsg.)Sleep297,99 €
-
-
-
Neuroimaging in Addiction presents an up-to-date, comprehensive review of the functional and structural imaging human studies that have greatly advanced our understanding of this complex disorder. Approaching addiction from a conceptual rather than a substance-specific perspective, this book integrates broad neuropsychological constructs that consider addiction as a neuroplastic process with genetic, developmental, and substance-induced contributions. The internationally recognized contributors to this volume are leaders in clinical imaging with expertise that spans the addiction spectrum. Following a general introduction, an overview of neural circuitry and modern non-invasive imaging techniques provides the framework for subsequent chapters on reward salience, craving, stress, impulsivity and cognition. Additional topics include the use of neuroimaging for the assessment of acute drug effects, drug-induced neurotoxicity, non-substance addictive behaviors, and the application of imaging genetics to identify unique intermediate phenotypes. The book concludes with an exploration of the future promise for functional imaging as guide to the diagnosis and treatment of addictive disorders. Scientists and clinicians will find the material in this volume invaluable in their work towards understanding the addicted brain, with the overall goal of improved prevention and treatment outcomes for patients. Features a Foreword by Edythe London, Director of the Center for Addictive Behaviors, University of California at Los Angeles.
Produktdetails
- Produktdetails
- Verlag: John Wiley & Sons / Wiley
- Seitenzahl: 376
- Erscheinungstermin: 7. November 2011
- Englisch
- Abmessung: 249mm x 170mm x 25mm
- Gewicht: 885g
- ISBN-13: 9780470660140
- ISBN-10: 0470660147
- Artikelnr.: 33684778
- Verlag: John Wiley & Sons / Wiley
- Seitenzahl: 376
- Erscheinungstermin: 7. November 2011
- Englisch
- Abmessung: 249mm x 170mm x 25mm
- Gewicht: 885g
- ISBN-13: 9780470660140
- ISBN-10: 0470660147
- Artikelnr.: 33684778
Dr. Adinoff is the Chief of the Division on Addictions in the Department of Psychiatry at University of Texas Southwestern Medical Center in Dallas and a staff psychiatrist at the VA North Texas Health Care System. He also holds the Distinguished Professorship of Alcohol and Drug Abuse Research at UT Southwestern. Dr. Adinoff obtained his medical training at Michigan State University and completed his residency in psychiatry at Tulane University. Following a fellowship and attending position in the Laboratory of Clinical Studies at the National Institutes on Alcohol Abuse and Alcoholism, Dr. Adinoff joined the faculty of the Medical University of South Carolina as director of the substance abuse program at the Ralph H. Johnson VA Medical Center. Dr. Adinoff's laboratory has used a variety of pharmacologic, cognitive, and behavioral probes to explore the neural and endocrine disruptions that occur following chronic cocaine or alcohol abuse and, more recently, compulsive tanning. Dr. Adinoff has published over 100 articles, reviews, and book chapters on the biology and treatment of addiction. He is also active in teaching trainees and colleagues how the brain disruptions uncovered by neuroimaging research relate to relapse and recovery. Dr. Elliot Stein is Chief of the Neuroimaging Research Branch at the National Institute on Drug Abuse Intramural Research Program (NIDA-IRP). Prior to coming to NIDA in 2002, he was Professor of Psychiatry at the Medical College of Wisconsin (MCW), where he was also Professor in the Departments of Pharmacology, Neurobiology and the Biophysics Research Institute. He received his PhD from the University of Maryland School of Medicine in neurophysiology and completed a post-doctoral fellowship at the California Institute of Technology with James Olds, a pioneer in brain reward systems. His lab pioneered the development and application of fMRI to study the neurobiology of human drug abuse. His research program employs multiple MR imaging modalities (including MR spectroscopy, BOLD activation, functional connectivity and diffusion tensor imaging) to define those neuronal systems mediating the actions of such abused drugs as nicotine and cocaine, to determine CNS sites and mechanisms responsible for mediating drug craving and reinforcement, and how drugs interact with specific cognitive and affective processes to alterbehavior. His research also incorporates preclinical models to translationally link the more mechanistic preclinical work with the more observational human studies. He has more than 400 authored papers, abstracts, reviews and book chapters in the field of drug addiction.
Foreword xi Edythe D. London List of Contributors xv 1 Introduction 3 Bryon
Adinoff and Elliot A. Stein References 5 2 An Integrated Framework for
Human Neuroimaging Studies of Addiction from a Preclinical Perspective 9
Karen D. Ersche and Trevor W. Robbins 2.1 Introduction 9 2.2 A Conceptual
Framework for Understanding Drug Addiction Based on Preclinical
Observations 9 2.3 Neuropharmacological Considerations 15 2.4
Neuropathology of Chronic Drug Abuse 15 2.5 Impulsivity: An Endophenotype
for Drug Addiction 17 2.6 Compulsivity: Craving versus Drug-Seeking 20 2.7
Summary 25 References 26 3 Structural and Functional Neuroimaging Methods:
Applications to Substance Abuse and Addiction 39 Yihong Yang, Svetlana
Chefer, Xiujuan Geng, Hong Gu, Xi Chen, and Elliot A. Stein 3.1
Introduction 39 3.2 MRI Based Imaging Tools and their Application to Drug
Abuse Research 40 3.3 Molecular Imaging with PET and SPECT 59 3.4 Summary
and Peek into the Future 69 References 69 4 Functional Neuroimaging of the
Acute Effects of Drugs of Abuse 85 Laurence John Reed and David J. Nutt 4.1
Introduction 85 4.2 Fundamental Neuronal Systems Related to Abuse Liability
in Humans 86 4.3 Psychostimulants 87 4.4 Alcohol 92 4.5 Cannabis and the
Cannabinoids 95 4.6 Opioids 96 4.7 Conclusions and Future Directions 98
References 99 5 Reward Processing 107 Anne Beck, Anthony A. Grace, and
Andreas Heinz 5.1 Introduction 107 5.2 Neurotransmitter Systems Implicated
in Reward Processing 107 5.3 Neurotransmitter Systems Involved in
Drug-Related Reward Processing 110 5.4 Alterations in the Mesostriatal
System in Addiction 116 5.5 Summary and Outlook 122 5.6 Acknowledgments 123
References 123 6 A Neuroimaging Approach to the Study of Craving 133
Francesca M. Filbey, Eric D. Claus, and Kent. E. Hutchison 6.1 A
Neuroimaging Approach to the Study of Craving 133 6.2 Neural Response
During Cue-Elicited Craving 134 6.3 Associations between Neural and
Subjective Response During Cue-Elicited Craving 141 6.4 Modulators of
Neural Response During Cue-Elicited Craving 142 6.5 Effects of Intervention
on the Neural Response During Cue-Elicited Craving 147 6.6 Summary and
Integration of Findings 149 6.7 Conclusions 151 References 151 7
Impulsivity and Addiction 159 Hugh Garavan 7.1 Introduction 159 7.2
Impulsivity as Reward versus Control 159 7.3 The Neurobiology of
Impulsivity 161 7.4 Impulsivity and Risk for Developing a Drug Use Disorder
163 7.5 Impulsivity in Current Users 165 7.6 Impulsivity, Abstinence, and
Relapse 168 7.7 Conclusion 170 References 171 8 Cognitive Disruptions in
Drug Addiction: a Focus on the Prefrontal Cortex 179 Rita Z. Goldstein,
Scott J. Moeller, and Nora D. Volkow 8.1 Introduction 179 8.2 Attention 181
8.3 Working Memory 190 8.4 Decision-Making 193 8.5 Pre-Morbid
Vulnerabilities 198 8.6 Other Brain Regions 198 8.7 Limitations Across All
Studies 199 8.8 Treatment Implications 200 8.9 General Summary and
Conclusions 200 8.10 Acknowledgments 201 References 201 9 Neural Mechanisms
of Stress and Addiction 211 Dongju Seo and Rajita Sinha 9.1 Stress and
Addiction 211 9.2 Neural Circuits of Stress Regulation 212 9.3 Dysfunction
in the Neural Circuits Underlying Stress and Addiction 218 9.4 Interplay of
Gene, Stress, and Drug Intake 222 9.5 Acknowledgments 224 References 224 10
Anatomical and Neurochemical Evidence of Neurotoxic Changes in
Psychostimulant Abuse and Dependence 237 Young Hoon Sung and Perry F.
Renshaw 10.1 Introduction 237 10.2 Characteristics of Psychostimulants 238
10.3 Quantitative MR Morphology Changes Associated with Psychostimulant
Dependence 239 10.4 Gross Anatomic Changes in Brain Structures and Subtle
Neurotoxicity 240 10.5 Relationship between Errant Neuromodulation by Drug
Abuse and Cognitive Abnormalities 241 10.6 Neurochemical Alterations and
Psychostimulant Dependence 244 10.7 Abnormal White Matter Integrity in
Psychostimulant Dependence 249 10.8 Alcohol and Opiate Addiction 251 10.9
Conclusion 252 References 253 11 Neuroimaging in Behavioral Addictions 263
Bryon Adinoff and Cythnia R. Harrington 11.1 Introduction 263 11.2
Diagnostic Considerations 264 11.3 Mesostriatal Dopamine Pathway 265 11.4
Reward 269 11.5 Craving 273 11.6 Future Directions 277 References 279 12
Imaging Genetics and Addiction 287 Vibhuti Srivastava and David Goldman
12.1 Introduction 287 12.2 Domains of Vulnerability 289 12.3 Cognitive
Function 300 12.4 Brain Morphometric Changes 301 12.5 Bridging Gaps 302
12.6 Imaging Pharmacogenetics 304 12.7 Conclusion 306 Glossary 308
References 309 13 The Diagnostic and Therapeutic Potential of Neuroimaging
in Addiction Medicine 321 Martina Reske and Martin P. Paulus 13.1 Can fMRI
Become the ECG in Addiction Medicine, or What Are the Treatment
Implications of Neuroimaging Research in Drug Addiction? 321 13.2
Functional Neuroimaging in Addiction: Relevant Cognitive Constructs to
Address during Treatment 322 13.3 Drug Challenge Studies Enhance Knowledge
on Pharmacokinetics and Drug-Experience-Relationships 325 13.4 Imaging
Symptom Severity 325 13.5 Neuroimaging-Based Monitoring of Treatment
Regimes and the Prediction of Treatment Outcomes 326 13.6 Assessing the
Relapse Potential Using fMRI 329 13.7 Neurofeedback as a Therapeutic
Approach? 334 13.8 Methodological Challenges to Utilize Functional
Neuroimaging as a Clinical Test 335 13.9 The Near Future of Brain Imaging
in Addiction Medicine 336 References 338 Index 345
Adinoff and Elliot A. Stein References 5 2 An Integrated Framework for
Human Neuroimaging Studies of Addiction from a Preclinical Perspective 9
Karen D. Ersche and Trevor W. Robbins 2.1 Introduction 9 2.2 A Conceptual
Framework for Understanding Drug Addiction Based on Preclinical
Observations 9 2.3 Neuropharmacological Considerations 15 2.4
Neuropathology of Chronic Drug Abuse 15 2.5 Impulsivity: An Endophenotype
for Drug Addiction 17 2.6 Compulsivity: Craving versus Drug-Seeking 20 2.7
Summary 25 References 26 3 Structural and Functional Neuroimaging Methods:
Applications to Substance Abuse and Addiction 39 Yihong Yang, Svetlana
Chefer, Xiujuan Geng, Hong Gu, Xi Chen, and Elliot A. Stein 3.1
Introduction 39 3.2 MRI Based Imaging Tools and their Application to Drug
Abuse Research 40 3.3 Molecular Imaging with PET and SPECT 59 3.4 Summary
and Peek into the Future 69 References 69 4 Functional Neuroimaging of the
Acute Effects of Drugs of Abuse 85 Laurence John Reed and David J. Nutt 4.1
Introduction 85 4.2 Fundamental Neuronal Systems Related to Abuse Liability
in Humans 86 4.3 Psychostimulants 87 4.4 Alcohol 92 4.5 Cannabis and the
Cannabinoids 95 4.6 Opioids 96 4.7 Conclusions and Future Directions 98
References 99 5 Reward Processing 107 Anne Beck, Anthony A. Grace, and
Andreas Heinz 5.1 Introduction 107 5.2 Neurotransmitter Systems Implicated
in Reward Processing 107 5.3 Neurotransmitter Systems Involved in
Drug-Related Reward Processing 110 5.4 Alterations in the Mesostriatal
System in Addiction 116 5.5 Summary and Outlook 122 5.6 Acknowledgments 123
References 123 6 A Neuroimaging Approach to the Study of Craving 133
Francesca M. Filbey, Eric D. Claus, and Kent. E. Hutchison 6.1 A
Neuroimaging Approach to the Study of Craving 133 6.2 Neural Response
During Cue-Elicited Craving 134 6.3 Associations between Neural and
Subjective Response During Cue-Elicited Craving 141 6.4 Modulators of
Neural Response During Cue-Elicited Craving 142 6.5 Effects of Intervention
on the Neural Response During Cue-Elicited Craving 147 6.6 Summary and
Integration of Findings 149 6.7 Conclusions 151 References 151 7
Impulsivity and Addiction 159 Hugh Garavan 7.1 Introduction 159 7.2
Impulsivity as Reward versus Control 159 7.3 The Neurobiology of
Impulsivity 161 7.4 Impulsivity and Risk for Developing a Drug Use Disorder
163 7.5 Impulsivity in Current Users 165 7.6 Impulsivity, Abstinence, and
Relapse 168 7.7 Conclusion 170 References 171 8 Cognitive Disruptions in
Drug Addiction: a Focus on the Prefrontal Cortex 179 Rita Z. Goldstein,
Scott J. Moeller, and Nora D. Volkow 8.1 Introduction 179 8.2 Attention 181
8.3 Working Memory 190 8.4 Decision-Making 193 8.5 Pre-Morbid
Vulnerabilities 198 8.6 Other Brain Regions 198 8.7 Limitations Across All
Studies 199 8.8 Treatment Implications 200 8.9 General Summary and
Conclusions 200 8.10 Acknowledgments 201 References 201 9 Neural Mechanisms
of Stress and Addiction 211 Dongju Seo and Rajita Sinha 9.1 Stress and
Addiction 211 9.2 Neural Circuits of Stress Regulation 212 9.3 Dysfunction
in the Neural Circuits Underlying Stress and Addiction 218 9.4 Interplay of
Gene, Stress, and Drug Intake 222 9.5 Acknowledgments 224 References 224 10
Anatomical and Neurochemical Evidence of Neurotoxic Changes in
Psychostimulant Abuse and Dependence 237 Young Hoon Sung and Perry F.
Renshaw 10.1 Introduction 237 10.2 Characteristics of Psychostimulants 238
10.3 Quantitative MR Morphology Changes Associated with Psychostimulant
Dependence 239 10.4 Gross Anatomic Changes in Brain Structures and Subtle
Neurotoxicity 240 10.5 Relationship between Errant Neuromodulation by Drug
Abuse and Cognitive Abnormalities 241 10.6 Neurochemical Alterations and
Psychostimulant Dependence 244 10.7 Abnormal White Matter Integrity in
Psychostimulant Dependence 249 10.8 Alcohol and Opiate Addiction 251 10.9
Conclusion 252 References 253 11 Neuroimaging in Behavioral Addictions 263
Bryon Adinoff and Cythnia R. Harrington 11.1 Introduction 263 11.2
Diagnostic Considerations 264 11.3 Mesostriatal Dopamine Pathway 265 11.4
Reward 269 11.5 Craving 273 11.6 Future Directions 277 References 279 12
Imaging Genetics and Addiction 287 Vibhuti Srivastava and David Goldman
12.1 Introduction 287 12.2 Domains of Vulnerability 289 12.3 Cognitive
Function 300 12.4 Brain Morphometric Changes 301 12.5 Bridging Gaps 302
12.6 Imaging Pharmacogenetics 304 12.7 Conclusion 306 Glossary 308
References 309 13 The Diagnostic and Therapeutic Potential of Neuroimaging
in Addiction Medicine 321 Martina Reske and Martin P. Paulus 13.1 Can fMRI
Become the ECG in Addiction Medicine, or What Are the Treatment
Implications of Neuroimaging Research in Drug Addiction? 321 13.2
Functional Neuroimaging in Addiction: Relevant Cognitive Constructs to
Address during Treatment 322 13.3 Drug Challenge Studies Enhance Knowledge
on Pharmacokinetics and Drug-Experience-Relationships 325 13.4 Imaging
Symptom Severity 325 13.5 Neuroimaging-Based Monitoring of Treatment
Regimes and the Prediction of Treatment Outcomes 326 13.6 Assessing the
Relapse Potential Using fMRI 329 13.7 Neurofeedback as a Therapeutic
Approach? 334 13.8 Methodological Challenges to Utilize Functional
Neuroimaging as a Clinical Test 335 13.9 The Near Future of Brain Imaging
in Addiction Medicine 336 References 338 Index 345
Foreword xi Edythe D. London List of Contributors xv 1 Introduction 3 Bryon
Adinoff and Elliot A. Stein References 5 2 An Integrated Framework for
Human Neuroimaging Studies of Addiction from a Preclinical Perspective 9
Karen D. Ersche and Trevor W. Robbins 2.1 Introduction 9 2.2 A Conceptual
Framework for Understanding Drug Addiction Based on Preclinical
Observations 9 2.3 Neuropharmacological Considerations 15 2.4
Neuropathology of Chronic Drug Abuse 15 2.5 Impulsivity: An Endophenotype
for Drug Addiction 17 2.6 Compulsivity: Craving versus Drug-Seeking 20 2.7
Summary 25 References 26 3 Structural and Functional Neuroimaging Methods:
Applications to Substance Abuse and Addiction 39 Yihong Yang, Svetlana
Chefer, Xiujuan Geng, Hong Gu, Xi Chen, and Elliot A. Stein 3.1
Introduction 39 3.2 MRI Based Imaging Tools and their Application to Drug
Abuse Research 40 3.3 Molecular Imaging with PET and SPECT 59 3.4 Summary
and Peek into the Future 69 References 69 4 Functional Neuroimaging of the
Acute Effects of Drugs of Abuse 85 Laurence John Reed and David J. Nutt 4.1
Introduction 85 4.2 Fundamental Neuronal Systems Related to Abuse Liability
in Humans 86 4.3 Psychostimulants 87 4.4 Alcohol 92 4.5 Cannabis and the
Cannabinoids 95 4.6 Opioids 96 4.7 Conclusions and Future Directions 98
References 99 5 Reward Processing 107 Anne Beck, Anthony A. Grace, and
Andreas Heinz 5.1 Introduction 107 5.2 Neurotransmitter Systems Implicated
in Reward Processing 107 5.3 Neurotransmitter Systems Involved in
Drug-Related Reward Processing 110 5.4 Alterations in the Mesostriatal
System in Addiction 116 5.5 Summary and Outlook 122 5.6 Acknowledgments 123
References 123 6 A Neuroimaging Approach to the Study of Craving 133
Francesca M. Filbey, Eric D. Claus, and Kent. E. Hutchison 6.1 A
Neuroimaging Approach to the Study of Craving 133 6.2 Neural Response
During Cue-Elicited Craving 134 6.3 Associations between Neural and
Subjective Response During Cue-Elicited Craving 141 6.4 Modulators of
Neural Response During Cue-Elicited Craving 142 6.5 Effects of Intervention
on the Neural Response During Cue-Elicited Craving 147 6.6 Summary and
Integration of Findings 149 6.7 Conclusions 151 References 151 7
Impulsivity and Addiction 159 Hugh Garavan 7.1 Introduction 159 7.2
Impulsivity as Reward versus Control 159 7.3 The Neurobiology of
Impulsivity 161 7.4 Impulsivity and Risk for Developing a Drug Use Disorder
163 7.5 Impulsivity in Current Users 165 7.6 Impulsivity, Abstinence, and
Relapse 168 7.7 Conclusion 170 References 171 8 Cognitive Disruptions in
Drug Addiction: a Focus on the Prefrontal Cortex 179 Rita Z. Goldstein,
Scott J. Moeller, and Nora D. Volkow 8.1 Introduction 179 8.2 Attention 181
8.3 Working Memory 190 8.4 Decision-Making 193 8.5 Pre-Morbid
Vulnerabilities 198 8.6 Other Brain Regions 198 8.7 Limitations Across All
Studies 199 8.8 Treatment Implications 200 8.9 General Summary and
Conclusions 200 8.10 Acknowledgments 201 References 201 9 Neural Mechanisms
of Stress and Addiction 211 Dongju Seo and Rajita Sinha 9.1 Stress and
Addiction 211 9.2 Neural Circuits of Stress Regulation 212 9.3 Dysfunction
in the Neural Circuits Underlying Stress and Addiction 218 9.4 Interplay of
Gene, Stress, and Drug Intake 222 9.5 Acknowledgments 224 References 224 10
Anatomical and Neurochemical Evidence of Neurotoxic Changes in
Psychostimulant Abuse and Dependence 237 Young Hoon Sung and Perry F.
Renshaw 10.1 Introduction 237 10.2 Characteristics of Psychostimulants 238
10.3 Quantitative MR Morphology Changes Associated with Psychostimulant
Dependence 239 10.4 Gross Anatomic Changes in Brain Structures and Subtle
Neurotoxicity 240 10.5 Relationship between Errant Neuromodulation by Drug
Abuse and Cognitive Abnormalities 241 10.6 Neurochemical Alterations and
Psychostimulant Dependence 244 10.7 Abnormal White Matter Integrity in
Psychostimulant Dependence 249 10.8 Alcohol and Opiate Addiction 251 10.9
Conclusion 252 References 253 11 Neuroimaging in Behavioral Addictions 263
Bryon Adinoff and Cythnia R. Harrington 11.1 Introduction 263 11.2
Diagnostic Considerations 264 11.3 Mesostriatal Dopamine Pathway 265 11.4
Reward 269 11.5 Craving 273 11.6 Future Directions 277 References 279 12
Imaging Genetics and Addiction 287 Vibhuti Srivastava and David Goldman
12.1 Introduction 287 12.2 Domains of Vulnerability 289 12.3 Cognitive
Function 300 12.4 Brain Morphometric Changes 301 12.5 Bridging Gaps 302
12.6 Imaging Pharmacogenetics 304 12.7 Conclusion 306 Glossary 308
References 309 13 The Diagnostic and Therapeutic Potential of Neuroimaging
in Addiction Medicine 321 Martina Reske and Martin P. Paulus 13.1 Can fMRI
Become the ECG in Addiction Medicine, or What Are the Treatment
Implications of Neuroimaging Research in Drug Addiction? 321 13.2
Functional Neuroimaging in Addiction: Relevant Cognitive Constructs to
Address during Treatment 322 13.3 Drug Challenge Studies Enhance Knowledge
on Pharmacokinetics and Drug-Experience-Relationships 325 13.4 Imaging
Symptom Severity 325 13.5 Neuroimaging-Based Monitoring of Treatment
Regimes and the Prediction of Treatment Outcomes 326 13.6 Assessing the
Relapse Potential Using fMRI 329 13.7 Neurofeedback as a Therapeutic
Approach? 334 13.8 Methodological Challenges to Utilize Functional
Neuroimaging as a Clinical Test 335 13.9 The Near Future of Brain Imaging
in Addiction Medicine 336 References 338 Index 345
Adinoff and Elliot A. Stein References 5 2 An Integrated Framework for
Human Neuroimaging Studies of Addiction from a Preclinical Perspective 9
Karen D. Ersche and Trevor W. Robbins 2.1 Introduction 9 2.2 A Conceptual
Framework for Understanding Drug Addiction Based on Preclinical
Observations 9 2.3 Neuropharmacological Considerations 15 2.4
Neuropathology of Chronic Drug Abuse 15 2.5 Impulsivity: An Endophenotype
for Drug Addiction 17 2.6 Compulsivity: Craving versus Drug-Seeking 20 2.7
Summary 25 References 26 3 Structural and Functional Neuroimaging Methods:
Applications to Substance Abuse and Addiction 39 Yihong Yang, Svetlana
Chefer, Xiujuan Geng, Hong Gu, Xi Chen, and Elliot A. Stein 3.1
Introduction 39 3.2 MRI Based Imaging Tools and their Application to Drug
Abuse Research 40 3.3 Molecular Imaging with PET and SPECT 59 3.4 Summary
and Peek into the Future 69 References 69 4 Functional Neuroimaging of the
Acute Effects of Drugs of Abuse 85 Laurence John Reed and David J. Nutt 4.1
Introduction 85 4.2 Fundamental Neuronal Systems Related to Abuse Liability
in Humans 86 4.3 Psychostimulants 87 4.4 Alcohol 92 4.5 Cannabis and the
Cannabinoids 95 4.6 Opioids 96 4.7 Conclusions and Future Directions 98
References 99 5 Reward Processing 107 Anne Beck, Anthony A. Grace, and
Andreas Heinz 5.1 Introduction 107 5.2 Neurotransmitter Systems Implicated
in Reward Processing 107 5.3 Neurotransmitter Systems Involved in
Drug-Related Reward Processing 110 5.4 Alterations in the Mesostriatal
System in Addiction 116 5.5 Summary and Outlook 122 5.6 Acknowledgments 123
References 123 6 A Neuroimaging Approach to the Study of Craving 133
Francesca M. Filbey, Eric D. Claus, and Kent. E. Hutchison 6.1 A
Neuroimaging Approach to the Study of Craving 133 6.2 Neural Response
During Cue-Elicited Craving 134 6.3 Associations between Neural and
Subjective Response During Cue-Elicited Craving 141 6.4 Modulators of
Neural Response During Cue-Elicited Craving 142 6.5 Effects of Intervention
on the Neural Response During Cue-Elicited Craving 147 6.6 Summary and
Integration of Findings 149 6.7 Conclusions 151 References 151 7
Impulsivity and Addiction 159 Hugh Garavan 7.1 Introduction 159 7.2
Impulsivity as Reward versus Control 159 7.3 The Neurobiology of
Impulsivity 161 7.4 Impulsivity and Risk for Developing a Drug Use Disorder
163 7.5 Impulsivity in Current Users 165 7.6 Impulsivity, Abstinence, and
Relapse 168 7.7 Conclusion 170 References 171 8 Cognitive Disruptions in
Drug Addiction: a Focus on the Prefrontal Cortex 179 Rita Z. Goldstein,
Scott J. Moeller, and Nora D. Volkow 8.1 Introduction 179 8.2 Attention 181
8.3 Working Memory 190 8.4 Decision-Making 193 8.5 Pre-Morbid
Vulnerabilities 198 8.6 Other Brain Regions 198 8.7 Limitations Across All
Studies 199 8.8 Treatment Implications 200 8.9 General Summary and
Conclusions 200 8.10 Acknowledgments 201 References 201 9 Neural Mechanisms
of Stress and Addiction 211 Dongju Seo and Rajita Sinha 9.1 Stress and
Addiction 211 9.2 Neural Circuits of Stress Regulation 212 9.3 Dysfunction
in the Neural Circuits Underlying Stress and Addiction 218 9.4 Interplay of
Gene, Stress, and Drug Intake 222 9.5 Acknowledgments 224 References 224 10
Anatomical and Neurochemical Evidence of Neurotoxic Changes in
Psychostimulant Abuse and Dependence 237 Young Hoon Sung and Perry F.
Renshaw 10.1 Introduction 237 10.2 Characteristics of Psychostimulants 238
10.3 Quantitative MR Morphology Changes Associated with Psychostimulant
Dependence 239 10.4 Gross Anatomic Changes in Brain Structures and Subtle
Neurotoxicity 240 10.5 Relationship between Errant Neuromodulation by Drug
Abuse and Cognitive Abnormalities 241 10.6 Neurochemical Alterations and
Psychostimulant Dependence 244 10.7 Abnormal White Matter Integrity in
Psychostimulant Dependence 249 10.8 Alcohol and Opiate Addiction 251 10.9
Conclusion 252 References 253 11 Neuroimaging in Behavioral Addictions 263
Bryon Adinoff and Cythnia R. Harrington 11.1 Introduction 263 11.2
Diagnostic Considerations 264 11.3 Mesostriatal Dopamine Pathway 265 11.4
Reward 269 11.5 Craving 273 11.6 Future Directions 277 References 279 12
Imaging Genetics and Addiction 287 Vibhuti Srivastava and David Goldman
12.1 Introduction 287 12.2 Domains of Vulnerability 289 12.3 Cognitive
Function 300 12.4 Brain Morphometric Changes 301 12.5 Bridging Gaps 302
12.6 Imaging Pharmacogenetics 304 12.7 Conclusion 306 Glossary 308
References 309 13 The Diagnostic and Therapeutic Potential of Neuroimaging
in Addiction Medicine 321 Martina Reske and Martin P. Paulus 13.1 Can fMRI
Become the ECG in Addiction Medicine, or What Are the Treatment
Implications of Neuroimaging Research in Drug Addiction? 321 13.2
Functional Neuroimaging in Addiction: Relevant Cognitive Constructs to
Address during Treatment 322 13.3 Drug Challenge Studies Enhance Knowledge
on Pharmacokinetics and Drug-Experience-Relationships 325 13.4 Imaging
Symptom Severity 325 13.5 Neuroimaging-Based Monitoring of Treatment
Regimes and the Prediction of Treatment Outcomes 326 13.6 Assessing the
Relapse Potential Using fMRI 329 13.7 Neurofeedback as a Therapeutic
Approach? 334 13.8 Methodological Challenges to Utilize Functional
Neuroimaging as a Clinical Test 335 13.9 The Near Future of Brain Imaging
in Addiction Medicine 336 References 338 Index 345